The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change.

CPAP was more preferred by providers as treatment for obstructive sleep apnea, while patients preferred tirzepatide.

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

First-line treatment with alectinib and bevacizumab appears to be effective for patients with ALK-rearranged, metastatic NSCLC, according to researchers.

Among patients with PAH, macitentan was associated with a decreased risk for all-cause and PAH-related hospitalization.